We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-0.91%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$128M
AUM Growth
-$21.3M
Cap. Flow
-$12.5M
Cap. Flow %
-9.73%
Top 10 Hldgs %
52.36%
Holding
99
New
13
Increased
31
Reduced
37
Closed
15

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$1.22M
2
ISRG icon
Intuitive Surgical
ISRG
+$1.22M
3
THC icon
Tenet Healthcare
THC
+$1.19M
4
RDNT icon
RadNet
RDNT
+$1.18M
5
CVRX icon
CVRx
CVRX
+$967K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$2.6M
2
GILD icon
Gilead Sciences
GILD
+$1.99M
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.43M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$1.34M
5
HCAT icon
Health Catalyst
HCAT
+$1.13M

Sector Composition

Rank Sector Weight
1 Healthcare 99.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPCR icon
51
Structure Therapeutics
GPCR
$3.44B
$583K 0.45%
33,695
-15,555
-32% -$381K
BBIO icon
52
BridgeBio Pharma
BBIO
$15.7B
$556K 0.43%
16,085
+4,585
+40% +$155K
TRVI icon
53
Trevi Therapeutics
TRVI
$2.54B
$515K 0.4%
+81,800
New +$390K
ROIV icon
54
Roivant Sciences
ROIV
$24.1B
$493K 0.38%
48,907
+14,407
+42% +$156K
COGT icon
55
Cogent Biosciences
COGT
$6.64B
$473K 0.37%
79,020
+5,220
+7% +$40.9K
PTCT icon
56
PTC Therapeutics
PTCT
$5.68B
$426K 0.33%
8,350
+2,550
+44% +$127K
BIIB icon
57
Biogen
BIIB
$29.8B
$391K 0.3%
2,855
-997
-26% -$143K
INCY icon
58
Incyte
INCY
$24B
$372K 0.29%
6,145
+3,645
+146% +$254K
SGOV icon
59
iShares 0-3 Month Treasury Bond ETF
SGOV
$99.9B
$361K 0.28%
3,589
-4,411
-55% -$443K
ASND icon
60
Ascendis Pharma A/S
ASND
$16B
$326K 0.25%
2,091
+491
+31% +$70.1K
NBIX icon
61
Neurocrine Biosciences
NBIX
$16.9B
$321K 0.25%
2,905
-8,895
-75% -$1.13M
RCKT icon
62
Rocket Pharmaceuticals
RCKT
$372M
$296K 0.23%
44,383
+4,200
+10% +$41.5K
ILMN icon
63
Illumina
ILMN
$29.9B
$292K 0.23%
3,682
-688
-16% -$74.5K
RPRX icon
64
Royalty Pharma
RPRX
$25.3B
$289K 0.22%
9,280
+2,080
+29% +$65.9K
IONS icon
65
Ionis Pharmaceuticals
IONS
$9.06B
$285K 0.22%
9,440
+2,240
+31% +$73.4K
JAZZ icon
66
Jazz Pharmaceuticals
JAZZ
$15.8B
$282K 0.22%
2,274
+524
+30% +$68.4K
MDGL icon
67
Madrigal Pharmaceuticals
MDGL
$11.1B
$242K 0.19%
730
+160
+28% +$52.6K
UTHR icon
68
United Therapeutics
UTHR
$21.9B
$236K 0.18%
765
+170
+29% +$58.3K
RVMD icon
69
Revolution Medicines
RVMD
$38.8B
$221K 0.17%
6,240
+1,340
+27% +$54.4K
RCUS icon
70
Arcus Biosciences
RCUS
$3.47B
$211K 0.16%
26,870
-42,682
-61% -$495K
NVO
71
Novo Nordisk
NVO
$208B
$198K 0.15%
2,850
+650
+30% +$53.7K
CRNX icon
72
Crinetics Pharmaceuticals
CRNX
$8.89B
$192K 0.15%
5,710
+1,310
+30% +$48.9K
AVBP icon
73
ArriVent BioPharma
AVBP
$1.38B
$187K 0.15%
+10,090
New +$247K
VTRS icon
74
Viatris
VTRS
$20.5B
$172K 0.13%
19,800
+4,200
+27% +$44.1K
MEDP icon
75
Medpace
MEDP
$16B
$162K 0.13%
531
-299
-36% -$101K
1 2
3
4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return
BIS
BG Investment Services Hagatna, Guam $120M AUM 17.44% 1-Year Est. Return

Sectoral Asset Management's Q1 2025 Portfolio in Review

As of Q1 2025, Sectoral Asset Management held 99 positions worth $128M, down 14% from $150M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Sectoral Asset Management withdrew a net $12.5M in Q1 2025, closing 15 positions and reducing 37 holdings. Its most notable exit was Sarepta Therapeutics, an estimated $1.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier.

Against the trend, Sectoral Asset Management opened a new position in DexCom worth $1.02M.

  • Sectoral Asset Management's largest Q1 2025 buy was DexCom: 15,000 shares worth $1.02M.
  • Sectoral Asset Management added most to Intuitive Surgical in Q1 2025, an estimated $1.22M increase.
  • Sectoral Asset Management's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $2.6M.
  • Sectoral Asset Management fully exited Sarepta Therapeutics in Q1 2025, selling an estimated $1.34M.
  • Sectoral Asset Management's ten largest holdings make up 52% of its $128M portfolio in Q1 2025.
  • Sectoral Asset Management opened 13 new positions and closed 15 in Q1 2025.
  • Sectoral Asset Management's portfolio value fell 14% quarter-over-quarter to $128M.

Based on Sectoral Asset Management's 13F filing for Q1 2025, filed 15 May 2025.